Skip to main content

Table 3 Participants’ C-Mill scores across the two time-points

From: Cerebellar tDCS combined with augmented reality treadmill for freezing of gait in Parkinson’s disease: a randomized controlled trial

 

tDCS groups

T0

(Mean ± SD)

T1

(Mean ± SD)

SupCoP

   
 

Cerebellar

117.8 ± 51.4

(56.2-201-4)

161.2 ± 83.8

(0-259.5)

 

Sham

144.8 ± 73.6

(24.7-276.2)

163.7 ± 65.5

(67.2-264.8)

ML

   
 

Cerebellar

19.5 ± 3.9

(13.1–23.5)

20.1 ± 8.3

(0-28.8)

 

Sham

22.3 ± 4.1

(15.6–28.8)

23.7 ± 3.6

(19.6–28.8)

AP

   
 

Cerebellar

11.8 ± 3.8

(7.4–17.7)

14.9 ± 8.6

(1.8–30.4)

 

Sham

15.2 ± 4.1

(9.6–22.4)

13.9 ± 5

(6.6–18.9)

OAD

   
 

Cerebellar

1.29 ± 2

(0-4.8)

5 ± 3.2

(0-9.7)

 

Sham

2.7 ± 2.1

(0-6.3)

1.2 ± 1.7

(0-3.6)

OAS

   
 

Cerebellar

3.9 ± 1.7

(2.4-8)

4.5 ± 2.6

(2-10.5)

 

Sham

3.4 ± 0.8

(2.6–5.1)

3.4 ± 0.6

(2.7–4.4)

OCD

   
 

Cerebellar

1 ± 2.2

(0-6.1)

4 ± 2.7

(0-9.9)

 

Sham

2.5 ± 1.7

(0-4.3)

1.4 ± 2.1

(0-5.1)

OCS

   
 

Cerebellar

5 ± 2.6

(2.7–10.6)

4.7 ± 2.7

(2.4–10.6)

 

Sham

3.9 ± 1.1

(2.7–6.2)

3.8 ± 0.7

(2.7–4.8)

TD

   
 

Cerebellar

10.5 ± 9.3

(4.9–33.3)

8.4 ± 5.7

(3-19.2)

 

Sham

7 ± 2.6

(3.7–11.1)

6.5 ± 2.5

(3-10.5)

TS

   
 

Cerebellar

9.8 ± 5.7

(4-19.8)

8.1 ± 5.6

(2.8–18.6)

 

Sham

6.4 ± 2

(4.5–9.9)

7.4 ± 4.2

(3.6–16.4)

Dx

   
 

Cerebellar

12.1 ± 10.5

(2.7–37.7)

11.7 ± 14.8

(3-50.1)

 

Sham

9.6 ± 4.2

(3.6–15.6)

8.9 ± 3.7

(3.7–14.1)

Sx

   
 

Cerebellar

13.7 ± 7.9

(3.6–29.6)

12.2 ± 7.7

(2.7–25)

 

Sham

9.9 ± 3.9

(3.4–14.5)

9.8 ± 3.9

(3.6–14.6)

LPDx

   
 

Cerebellar

0.2 ± 0.1

(0-0.4)

0.3 ± 0.1

(0.2-0.4)

 

Sham

0.3 ± 0.1

(0.2-0.5)

0.4 ± 0.1

(0.2-0.5)

LPSx

   
 

Cerebellar

0.3 ± 0.1

(0.1-0.4)

0.4 ± 0.1

(0.2-0.5)

 

Sham

0.4 ± 0.1

(0.2-0.6)

0.4 ± 0.1

(0.3-0.6)

AmP

   
 

Cerebellar

0.2 ± 0.1

(0.1-0.2)

0.2 ± 0.1

(0.1-0.2)

 

Sham

0.1 ± 0

(0.1-0.2)

0.1 ± 0

(0.1-0.2)

DPDx

   
 

Cerebellar

188.6 ± 342.9

(49.7–1102)

78.5 ± 18.6

(51.6–103)

 

Sham

72.5 ± 19.5

(44.9–107)

71.8 ± 19.3

(43.6–106)

DPSx

   
 

Cerebellar

77.4 ± 17.1

(51.7–103)

78.6 ± 17.9

(52.7–103)

 

Sham

73 ± 20

(44.7–108)

72.1 ± 19.4

(44–106)

LPDxO

   
 

Cerebellar

0.3 ± 0.1

(0-0.4)

0.4 ± 0.1

(0.2-0.4)

 

Sham

0.4 ± 0.1

(0.3-0.5)

0.4 ± 0.1

(0.3-0.5)

LPSxO

   
 

Cerebellar

0.3 ± 0.1

(0.1-0.4)

0.4 ± 0.1

(0.3-0.4)

 

Sham

0.4 ± 0.1

(0.2-0.5)

0.4 ± 0.1

(0.3-0.4)

AmPO

   
 

Cerebellar

0.2 ± 0.1

(0.1-0.2)

0.2 ± 0

(0.1-0.2)

 

Sham

0.1 ± 0

(0.1-0.2)

0.1 ± 0

(0.1-0.2)

DPODx

   
 

Cerebellar

76.9 ± 18.2

(49.8–101)

79.9 ± 19.3

(51.2–103)

 

Sham

73 ± 20.3

(45.1–109)

72.5 ± 20.7

(44–106)

DPOSx

   
 

Cerebellar

76.6 ± 17.5

(50.8–99)

80.5 ± 17.8

(52.2–103)

 

Sham

72.9 ± 19.9

(44.9–107)

72.7 ± 20.8

(44–106)

  1. Notes AmP = Step Amplitude; AmPO = Step Amplitude-Obstacles; AP = Anterior-Posterior; DPDx = Right Step Distribution; DPODx = Right Step Distribution-Obstacles; DPOSx = Left Step Distribution-Obstacles; DPSx = Left Step Distribution; Dx = Right Leg; LPDx = Right Step Length; LPDxO = Right Step Length-Obstacles; LPSx = Left Step Length; LPSxO = Left Step Length-Obstacles; ML = Medio-Lateral; OAD = Eyes Open Right; OAS = Eyes Open Left; OCD = Eyes Closed Right; OCS = Eyes Closed Left; SupCoP = Postural Control Surface; Sx = Left Leg; TD = Tandem Right; TS = Tandem Left